Veradermics, Inc (MANE) IPO — S-1 Filing, Stock & Insider Activity

Veradermics, Inc IPO — Status & S-1 Filing

Ticker: MANE
Status: Priced — IPO complete
S-1 filed: 2026-01-09
Effective: 2026-04-29
IPO / pricing date: 2026-02-04
Exchange: NYSE
Offering price: $17.00
Shares offered: 15,077,647
SEC CIK: 0001827635 · View the S-1 on SEC EDGAR →

Track every registration update on the InsiderAlpha IPO tracker.

Updated Jul 16, 2026 · Last SEC filing 2026-05-06

Veradermics, Inc (MANE) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-06. 5 Form 8-K material event filings were reported by MANE in the last 90 days. InsiderAlpha tracks every MANE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Veradermics, Inc (MANE)

SEC CIK	0001827635

90-Day SEC Filing Activity

Form 4 filings (90d)	1
Form 8-K filings (90d)	5
Latest Form 4 filing	2026-05-06

Recent MANE Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-02-06	SUVRETTA CAPITAL MANAGEMENT, LLC	Insider	P — Open-market purchase	11.2K	$35.97	$402K	SEC
2026-02-06	SUVRETTA CAPITAL MANAGEMENT, LLC	Insider	P — Open-market purchase	19.3K	$36.55	$707K	SEC
2026-02-05	Coric Vlad	Director	J — Other acquisition / disposition	33.7K	—	—	SEC
2026-02-05	Coric Vlad	Director	J — Other acquisition / disposition	148.8K	—	—	SEC
2026-02-05	Coric Vlad	Director	J — Other acquisition / disposition	148.8K	—	—	SEC
2026-02-05	Coric Vlad	Director	J — Other acquisition / disposition	78.1K	—	—	SEC
2026-02-05	Coric Vlad	Director	J — Other acquisition / disposition	117.1K	—	—	SEC
2026-02-05	Coric Vlad	Director	J — Other acquisition / disposition	78.1K	—	—	SEC
2026-02-05	Coric Vlad	Director	P — Open-market purchase	58.8K	$17.00	$1000K	SEC
2026-02-05	Coric Vlad	Director	P — Open-market purchase	58.8K	$17.00	$1000K	SEC
2026-02-05	CHILDS JOHN W	Director	J — Other acquisition / disposition	480.3K	—	—	SEC
2026-02-05	CHILDS JOHN W	Director	J — Other acquisition / disposition	906.9K	—	—	SEC
2026-02-05	CHILDS JOHN W	Director	J — Other acquisition / disposition	520.8K	—	—	SEC
2026-02-05	CHILDS JOHN W	Director	P — Open-market purchase	294.1K	$17.00	$5.00M	SEC
2026-02-05	Coric Vlad	Director	J — Other acquisition / disposition	33.7K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Veradermics, Inc (MANE). Updated in real time as new filings are submitted to the SEC.

Most-Active MANE Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
SUVRETTA CAPITAL MANAGEMENT, LLC	2	$30.00M

Recent MANE Form 8-K Material Events

2026-07-15 — Item 7.01, 8.01, 9.01 [SEC]
2026-05-12 — Item 2.02, 9.01 [SEC]
2026-05-01 — Item 1.01, 3.02, 9.01 [SEC]
2026-04-27 — Item 2.02 · Earnings · neutral [SEC]
Veradermics reported preliminary unaudited cash, cash equivalents, and marketable securities of approximately $390.8 million as of March 31, 2026. The company notes this preliminary financial data is subject to completion of financial closing procedures and may differ materially
2026-04-27 — Item 7.01, 8.01, 9.01 · Clinical · positive [SEC]
Veradermics announced positive topline data from its Phase 2/3 Study 302 evaluating VDPHL01 for male pattern hair loss. The trial met all primary and key secondary endpoints with statistical significance, demonstrating rapid onset, consistent response, and robust hair count incre

Recent Insider Filings

2026-05-06 — SUVRETTA CAPITAL MANAGEMENT, LLC (Insider)
2026-02-27 — CHILDS JOHN W (Director)
2026-02-09 — SUVRETTA CAPITAL MANAGEMENT, LLC (Insider)
2026-02-06 — Pance Katarina (Insider)
2026-02-06 — Grant-Kels Jane M. (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in MANE insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

MANE Insider Trading — FAQ

What is the latest insider trade for MANE?: Veradermics, Inc (MANE) had 1 insider filings in the last 90 days, with the most recent on 2026-05-06. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying MANE stock?: 0 insider purchases of MANE were filed in the last 90 days.
How many insiders are selling MANE stock?: 0 insider sales of MANE were filed in the last 90 days.
Where can I see MANE SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every MANE SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live MANE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.